A phase II study of neuroimmunotherapy with subcutaneous low-dose IL-2 plus the pineal hormone melatonin in untreatable advanced hematologic malignancies.
Year: 2000
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: P Lissoni, S Bolis, F Brivio, L Fumagalli
Institution: Azienda Ospedaliera San Gerardo
Language: English
Subfield: Endocrine and Autonomic Systems
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2404328035
